Last --
Change Today 0.00 / 0.00%
Volume 0.0
CARD On Other Exchanges
All times are local (Market data is delayed by at least 15 minutes).

cardigant medical inc (CARD) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CARDIGANT MEDICAL INC (CARD)

Related News

No related news articles were found.

cardigant medical inc (CARD) Related Businessweek News

No Related Businessweek News Found

cardigant medical inc (CARD) Details

Cardigant Medical, Inc., a development stage biotechnology company, focuses on the development of novel biologic compounds and methods for local delivery for the treatment of acute coronary syndromes, carotid stenosis, and aortic valve stenosis. It plans to treat atherosclerosis and plaque stabilization using systemic and local delivery of large molecule therapeutics based on high density lipoprotein targets. The company’s lead drug product is based on the AApoA-1 protein, which has a specific role in the metabolism of lipids. Cardigant Medical, Inc. was founded in 2009 and is headquartered in Manhattan Beach, California.

1 Employees
Last Reported Date: 04/8/14
Founded in 2009

cardigant medical inc (CARD) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: --
Chief Scientific officer and Vice President
Total Annual Compensation: --
Chief Medical officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

cardigant medical inc (CARD) Key Developments

Cardigant Medical Inc. Auditor Raises 'Going Concern' Doubt

Cardigant Medical Inc. filed its 10-K on Apr 07, 2014 for the period ending Dec 31, 2013. In this report its auditor, Jonathon P. Reuben, CPA, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Cardigant Medical Inc. announced delayed annual 10-K filing

On 03/31/2014, Cardigant Medical Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Cardigant Medical Inc. Announces Executive Changes

Cardigant Medical Inc. announced effective October 15, 2013, Jack R. A. Mott has informed the company of his decision to resign from his position as chief financial officer. Mr. Mott has served as the company's chief financial officer since September of2012. In the interim, the company's chief executive officer will assume the role of chief financial officer until such suitable replacement is found.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CARD:US $0.00 USD 0.00

CARD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CARD.
View Industry Companies

Industry Analysis


Industry Average

Valuation CARD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIGANT MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at